Subject area |
Biochemistry |
More specific subject area |
Peptidomics, Ovarian Cancer Biomarkers |
Type of data |
Table, LC-MS/MS data and identification data |
How data were acquired |
Peptides were analyzed on a TripleTOF 5600+ mass spectrometer with a NanoSpray III ion source (Sciex, Canada) coupled with a NanoLC Ultra 2D+ nano-HPLC system (Eksigent, USA) |
Data format |
Raw and analyzed data |
Experimental factors |
6 ovarian cancer and 5 cirrhosis ascites samples; |
Serum samples from 20 ovarian cancer patients; |
Serum samples from 10 healthy donors. |
Experimental features |
Pools of 6 ovarian cancer ascites, 5 cirrhosis ascites, 10 serum samples from healthy donors and two pools of 10 ovarian cancer sera were fractionated using anion exchange QAE Sephadex A-25 sorbent and analyzed by LC-MS/MS. |
Data source location |
Federal Research and Clinical Center of Physical Chemical Medicine of the Federal Medical and Biological Agency of the Russian Federation, Malaya Pirogovskaya 1a, Moscow 119435, Russian Federation. |
Data accessibility |
Data are with this article. The LC-MS/MS data have been deposited to the ProteomeXchange Consortium via the PRIDE [6] partner repository with the dataset identifier PXD009382 and 10.6019/PXD009382. |
Direct download link: http://www.ebi.ac.uk/pride/archive/projects/PXD009382
|